Delivery Order SPE2DB20D3304-SPE2DB25FW9E0
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $6,549.99 to AmerisourceBergen Drug Corp on September 8, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.92 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This competitive award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction with no set-aside designation. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,650.04 for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award under the company's existing contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a $1,464.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and was performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without set-aside restrictions, reflecting the contractor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,833.48 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 pods (Generation 5) in 5-count packages. This firm fixed-price, non-set-aside contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The OmniPod 5 is an insulin delivery system widely used for diabetes management, and...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.08 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...